(Q33184311)
Statements
Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance (English)
D Seehofer
N Rayes
T Steinmüller
A R Müller
S Jonas
U Settmacher
R Neuhaus
1 September 2002